TY - JOUR
T1 - A Pilot Test for Implementing Precision Healthcare Programme in Patients with Diabetes in Indonesia
AU - Pranata, Satriya
AU - Wu, Shu Fang Vivienne
AU - Wang, Tsae Jyy Tiffany
AU - Liang, Shu Yuan
AU - Bistara, Difran Nobel
AU - Chuang, Yeu Hui
AU - Lu, Kuo Cheng
AU - Atmaja, Hadi Kusuma
N1 - Publisher Copyright:
© 2023 Pranataet al.
PY - 2023
Y1 - 2023
N2 - Background/Aim: An evaluation of precision healthcare interventions among patients with diabetes in a small sample through a pilot test before being tested in a larger sample is needed. Thus, the purpose of this study was to evaluate the feasibility of a precision healthcare programme. It also assesses the programme's outcome among patients with diabetes in Indonesia. Methods: Data were collected during December 2020. The researchers first gathered data about participant characteristics. Furthermore, the strategies of precision healthcare were implemented in sixty respondents to evaluate the feasibility and outcome of the programme in a month. Results: The participants mentioned that they can follow all procedures of precision healthcare. However, they asked the researcher to provide a guide and monitoring book which provides safe choices information on diet, exercise, glucose monitoring and drug medication. Moreover, participants mentioned that they could complete all questionnaires but needed a company of a research as-sistant. The benefits of a month of precision healthcare were improved diabetes self-care activity, blood pressure and blood glucose level. However, the body weight, body mass index (BMI), triglyceride, cholesterol and triglyceride glucose index were not significantly improved. Conclusion: A pilot test is needed to ensure the feasibility of the implementation strategy with the culture and background of diabetic patients in Indonesia. Improving diabetes self-care activity stabilised blood pressure and blood glucose during a month, so it can be assumed that precision healthcare approaches were potentially being applied in Indonesia. On the other hand, it is needed more than a month to improve body weight, BMI, triglyceride, cholesterol and triglyceride glucose index. Thus, testing the precision healthcare approach in a larger sample with long time series for patients with diabetes in Indonesia through a ran-domised controlled trial (RCT) is needed.
AB - Background/Aim: An evaluation of precision healthcare interventions among patients with diabetes in a small sample through a pilot test before being tested in a larger sample is needed. Thus, the purpose of this study was to evaluate the feasibility of a precision healthcare programme. It also assesses the programme's outcome among patients with diabetes in Indonesia. Methods: Data were collected during December 2020. The researchers first gathered data about participant characteristics. Furthermore, the strategies of precision healthcare were implemented in sixty respondents to evaluate the feasibility and outcome of the programme in a month. Results: The participants mentioned that they can follow all procedures of precision healthcare. However, they asked the researcher to provide a guide and monitoring book which provides safe choices information on diet, exercise, glucose monitoring and drug medication. Moreover, participants mentioned that they could complete all questionnaires but needed a company of a research as-sistant. The benefits of a month of precision healthcare were improved diabetes self-care activity, blood pressure and blood glucose level. However, the body weight, body mass index (BMI), triglyceride, cholesterol and triglyceride glucose index were not significantly improved. Conclusion: A pilot test is needed to ensure the feasibility of the implementation strategy with the culture and background of diabetic patients in Indonesia. Improving diabetes self-care activity stabilised blood pressure and blood glucose during a month, so it can be assumed that precision healthcare approaches were potentially being applied in Indonesia. On the other hand, it is needed more than a month to improve body weight, BMI, triglyceride, cholesterol and triglyceride glucose index. Thus, testing the precision healthcare approach in a larger sample with long time series for patients with diabetes in Indonesia through a ran-domised controlled trial (RCT) is needed.
KW - Genetic
KW - Patient preference
KW - Personalised
KW - Precision health
KW - Strategy
UR - http://www.scopus.com/inward/record.url?scp=85153251554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85153251554&partnerID=8YFLogxK
U2 - 10.5937/scriptamed54-42230
DO - 10.5937/scriptamed54-42230
M3 - Article
AN - SCOPUS:85153251554
SN - 2490-3329
VL - 54
SP - 61
EP - 67
JO - Scripta Medica (Banja Luka)
JF - Scripta Medica (Banja Luka)
IS - 1
ER -
